Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia

Journal of Applied Genetics

Volumn 44, Issue 3, 2003, Pages 401-412

  Brozek, Izabela ^a   Babińska, Małgorzata ^a   Kardaś, Iwona ^a   Woźniak, Agnieszka ^a   Balcerska, Anna ^a   Hellmann, Andrzej ^a   Limon, Janusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Acute leukaemia; ALL; AML; Chromosome 7; Chromosome aberrations

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; KARYOTYPE; MALE; PARTIAL MONOSOMY; SCHOOL CHILD;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE;

EID: 0141464970     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BLOOMFIELD C.D., SHUMA C., REGAL I., PHILIP P.P., HOSSFELD D.K., HAGEMEIJER A.M., GARSON O.M., PETERSON B.A., SAKURAI M., ALIMENA G., BERGER R., ROWLEY J.D., RUUTU T., MITELMAN F., DEWALD G.W., SWANSBURY J. (1997). Long-term survival of patients with acute myeloid leukemia. A third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 80: 2191-2198.
2. BYRD J.C., MRÓZEK K., DODGE R.K., CARROLL A.J., EDWARDS C.G., ARTHUR D.C., PETTENATI M.J., PATIL S.R., RAO K.W., WATSON M.S., KODURU P.R.K., MOORE J.O., STONE R.M., MAYER R.J., FELDMAN E.J., DAVEY F.R., SCHIFFER C.A., LARSON R.A., BLOOMFIELD C.D. (2002). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse and overall survival in adult patients with de novo acute myeloid leukemia: results from CALGB 8461. Blood DOI 10.1182/blood-2002-03-0772.
3. CASASNOVAS R.O., CAMPOS L., MUGNERET F., CHARRIN C., BENE M.C., GARAND R., FAVRE M., SARTIAUX C., CHAUMAREL I., BERNIER M., FAURE G. SOLARY E. (1998). Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients. Leukemia 12: 34-43.
4. DABAJA B.S., FADERL S., THOMAS D., CORTES J., O'BRIEN S., NASR F., PIERCE S., HAYES K., GLASSMAN A., KEATING M. KANTARJIAN H.M. (1999). Deletions and losses in chromosomes 5 and 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia 13: 869-872.
5. DASTUGUE N., PAYEN C., LAFAGE-POCHITALOFF M., BERNARD P., LEROUX D., HUGUET-RIGAL F., STOPPA A.-M., MARIT G., MOLINA L., MICHALLET M., MARANINCHI D., ATTAL M., REIFFERS J. (1995). Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 9: 1491-1498.
6. EL-RIFAI W., ELONEN E., LARRAMENDY M., RUUTU T., KNUUTILA S. (1997). Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. Leukemia 11: 958-963.
7. ESTEY E.H., PIERCE S., KEATING M.J. (2000). Identification of a group of AML/MDS patients with a relatively favourable prognosis who have chromosome 5 and/or 7 abnormalities. Haematologica 85: 246-249.
8. FERRANT A., LABOPIN M., FRASSONI F., PRENTICE H.G., CAHN J.Y., BLAISE D., REIFFERS J., VISANI G., SANZ M.A., BOOGAERTS M.A., LOWENBERG B., GORIN N.C. (1997). Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: A European Group for Blood and Marrow Transplantation Study. Blood 90: 2931-2938.
9. FISCHER K., FROHLING S., SCHERER S.W., MCALLISTER BROWN J., SCHOLL C., STILGENBAUER S., TSUI L.-C., LICHTER P., DOHNER H. (1997). Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89: 2036-2041.
10. FLEISCHMAN E.W., RESHMI S., SOKOVA O.I., KIRICHENKO O.P., KONSTANTINOVA L.N., KULAGINA O.E., FRENKEL M.A. (1999). Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet. Cytogenet. 108: 166-170.
11. GRIMWADE D., WALKER H., HARRISON G., OLIVER F., CHATTERS S., HARRISON C.J., WHEATLEY K., BURNETT A.K., GOLDSTONE A.H. (2001). The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial. Blood 98: 1312-20.
12. GRIMWADE D., WALKER H., OLIVER F., WHEATLEY K., HARRISON C., HARRISON G., REES J., HANN I., STEVENS R., BURNETT A., GOLDSTONE A. (1998). The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 Trial. Blood 92: 2322-33.
13. HASLE H., ARICO M., BASSO G., BIONDI A., CANTU RAJNOLDI A., CREUTZIG U., FENU S., FONATSCH C., HAAS O.A., HARBOTT J., KARDOS G., KERNDRUP G., MANN G., NIEMEYER C.M., PTOSZKOVA H., RITTER J., SLATER R., STARY J., STOLLMANN-GIBBELS B., TESTI A.M., VAN WERING E.R., ZIMMERMANN M. (1999). Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. Leukemia 13: 376-385.
14. HAUS O. (1998). Zmiany cytogenetyczne i molekularne w zespołach dysplastycznych i ich znaczenie kliniczne. Pol. Archw. Med. Wewn. 99: 114-122.
15. JOHANSSON B., MERTENS F., MITELMAN F. (1993). Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor supressor loci. Genes Chromosomes Cancer 8: 205-218.
16. KEARNEY L. (1999). The impact of the new FISH technologies on the cytogenetics of hematological malignancies. Br. J. Haematol. 104: 648-658.
17. KOIKE M., TASAKA T., SPIRA S., TSURUOKA N., KOEFFER H.P. (1999). Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505). Leuk. Res. 23: 307-10.
18. LEWIS S., ABRAHAMSON G., BOULTWOOD J., FIDLER C., POTTER A., WAINSCOAT J.S. (1996). Molecular characterisation of 7q deletion in myeloid disorders. Br. J. Haematol. 93: 75-80.
19. LIANG H., FAIRMAN J., CLAXTON D.F., NOWELL P.C., GREEN E.D., NAGARAJAN L. (1998). Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc. Natl. Acad. Sci. USA 95: 3781-5.
20. MAROSI C., KOLLER U., KOLLER-WEBER E., SCHWARZINGER I., SCHNEIDER B., JAGER U., VAHLS P., NOWOTNY H., PIRC-DANOEWINATA H., STEGER G., KREINER G., WAGNER B., LECHNER K., LUTZ D., BETTELHEIM P., HAAS O.A. (1992). Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genet. Cytogenet. 61: 14-25.
21. MAURITZSON N., JOHANSSON B., ALBIN M., BILLSTROM R., AHLGREN T., MIKOCZY Z., NILSSON P.G., HAGMAR L., MITELMAN F. (1999). A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur. J. Haematol. 62: 95-102.
22. MITELMAN F. (1995). An International System for Human Cytogenetic Nomenclature. Basel, Switzerland; Karger.
23. MITELMAN F. (2003). Database of Chromosome Aberrations in Cancer (F. Mitelman, B. Johansson, F. Mertens, eds.). http://cgap.nci.nih.gov/Chromosomes/Mitelman
24. MRÓZEK K., BLOOMFIELD C.D. (1998). Chromosome aberrations in de novo acute myeloid leukemia in adults: clinical implications. Rev. Clin. Exp. Hematol. 5: 44-67.
25. PERKINS D., BRENNAN S., CARSTAIRS K., BAILEY D., PANTALONY D., POON A., FERNANDES B., DUBE I. (1997). Regional cancer cytogenetics: A report on 1,143 diagnostic cases. Cancer Genet. Cytogenet. 96: 64-80.
26. SLOVAK M.L., KOPECKY K.J., CASSILETH P.A., HARRINGTON D.H., THEIL K.S., MOHAMED A., PAIETTA E., WILLMAN C.L., HEAD D.R., ROWE J.M., FORMAN S.J., APPELBAUM F.R. (2000). Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 96: 4075-83.
27. VELLOSO E.R.P., MICHAUX L., FERRANT A., HERNANDEZ J.M, MEEUS P., DIERLAMM J., CRIEL A., LOUWAGIE A., VERHOEF G., BOOGAERTS M., MICHAUX J.-L., BOSLY A., MECUCCI C., VAN DEN BERGHE H. (1996). Deletion of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Br. J. Haematol. 92: 574-581.
28. WETZLER M., DODGE R.K., MRÓZEK K., CARROLL A.J., TANTRAVAHI R., BLOCK A.W., PETTENATI M.J., LE BEAU M., FRANKEL S.R., STEWART C.C., SZATROWSKI T.P., SCHIFFER C.A., LARSON R.A., BLOOMFIELD C.D. (1999). Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience. Blood 93: 3983-3993.